PSA testing

Understanding PSA Testing

Prostate specific antigen (PSA) testing is one of the most widely used blood biomarker tests for assessing prostate health. PSA is a protein produced by both normal and cancerous prostate cells and measuring its level in the blood can help identify changes that may require further clinical evaluation.
Elevated PSA levels do not always indicate prostate cancer but it can indicate inflammation, benign prostatic hyperplasia (BPH), infection, or indeed, other prostate related conditions. Because of this, basic PSA testing is often used as the first step in a more comprehensive assessment, also offered here.
A simple blood test can help detect potential issues early—often before symptoms appear. Early detection is associated with better treatment options, improved outcomes and greater peace of mind.

remove the labels

Prostate Specific Antigen Test

  • Prostate Health 
  • Total Prostate specific Antigen 
  • Free Prostate Specific Antigen
  • Interleukin-8
  • Monocyte Chemotactic Protein-1
  • Epidermal Growth Factor
  • Prostate Cancer Risk Score
 Shop now

PSA testing is especially useful for men over 50, or earlier for those with additional risk factors such as family history or genetic predisposition to the disease.

Our approach integrates:
a) PSA testing and then optionally
b) advanced biomarker test and
c) genetic risk profiling.


Together, these tests offer an accurate and personalised view of prostate health.
Whether used for routine screening, early warning, or ongoing monitoring, these tools empower men to take proactive steps toward protecting their long term health.
PSA levels can rise for many non-cancerous reasons for example, a urinary tract infection or benign prostate enlargement (BPH). Nearly 75% of men with elevated PSA results who undergo further testing don't actually have prostate cancer. The advanced biomarker test helps cut through the confusion and gives you more peace of mind.
Genetic risk profiling has become an important component of prostate cancer screening strategies. Certain inherited gene variants—such as BRCA1, BRCA2, ATM, CHEK2, and others—can significantly increase a man’s lifetime risk of developing prostate cancer, particularly the aggressive forms. We screen for variants in 14 of the known prostate cancer associated genes.
A prostate cancer genetic risk profile can:
• Identify if you are at higher-than-average risk
• Guide personalised screening schedules
• Support early detection strategies
• Inform treatment decisions if cancer is suspected or diagnosed
Men with a family history of prostate, breast, ovarian, or pancreatic cancer may particularly benefit from a genetic assessment.

PSA Collection
Confident healthy man smiling on a sofa — Prostate Profile blood test for mens prostate health

Prostate Profile

Prostate Profile
£155.00

Frequently asked questions
How is this test different from a normal PSA test?

A standard PSA test only checks total PSA, which can be raised for many harmless reasons.
Our Prostate Profile goes much further, combining total PSA, free PSA, Interleukin‑8, MCP‑1, EGF, and a calculated Prostate Cancer Risk Score.
This multi‑marker approach gives a clearer picture of prostate health and reduces unnecessary follow‑ups.
Why do you include extra markers like Interleukin‑8, MCP‑1 and EGF?

These additional biomarkers help assess inflammation and other biological patterns linked to prostate health.
By analysing them alongside PSA levels, the test can classify your risk more accurately, rather than relying on one number.
It gives you a more complete, reliable assessment.
Who should consider taking this Prostate Profile?

This test is ideal for men who:

want a more detailed prostate assessment than standard PSA
have a family history of prostate conditions
want clearer guidance on whether follow‑up is needed
prefer a proactive approach to their health

It’s designed for anyone seeking a thorough, multi‑marker evaluation rather than a single PSA reading.
How does the Prostate Cancer Risk Score help me?

The Prostate Cancer Risk Score combines all measured biomarkers to classify your risk as low or high.
This gives clearer guidance for you — and your clinician — about whether further investigation is needed or if everything looks reassuring.
It takes the guesswork out of interpreting PSA results.
Does this test reduce the chance of unnecessary follow‑ups?

Yes! That’s one of its biggest benefits.
Instead of reacting to a single raised PSA level, the multi‑marker approach gives context, showing whether the rise is likely meaningful or not.
This helps avoid unneeded appointments, anxiety, or repeat testing.